APA (7th ed.) Citation

Frenking, J., Riedhammer, C., Teipel, R., Bassermann, F., Besemer, B., Bewarder, M., . . . Raab, M. (2025). A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma. HemaSphere, 9(4), . https://doi.org/10.1002/hem3.70114

Chicago Style (17th ed.) Citation

Frenking, Jan, et al. "A German Multicenter Real-world Analysis of Talquetamab in 138 Patients with Relapsed/refractory Multiple Myeloma." HemaSphere 9, no. 4 (2025). https://doi.org/10.1002/hem3.70114.

MLA (9th ed.) Citation

Frenking, Jan, et al. "A German Multicenter Real-world Analysis of Talquetamab in 138 Patients with Relapsed/refractory Multiple Myeloma." HemaSphere, vol. 9, no. 4, 2025, https://doi.org/10.1002/hem3.70114.